Open Label Trial of Therapeutic Hepatitis B Vaccine V-5 Immunitor (V5)Delivered by Oral Route

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|4|8|540-544

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.4, Iss.8, 2007-12, pp. : 540-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3733-3742

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient HAdV-5: A Qualitative Modelling Approach

By  

Current Gene Therapy, Vol. 10, Iss. 2, 2010-04 ,pp. : 107-127

Bentham Science Publishers

Access to resources Recommend Favorite

Is An Oral Plant-based Vaccine against Hepatitis B Virus Possible?

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 15, 2012-12 ,pp. : 2692-2704

Bentham Science Publishers

Access to resources Recommend Favorite

Comments on donepezil open label trial

By Charlesworth G.   Shepstone L.  

European Neuropsychopharmacology, Vol. 9, Iss. 5, 1999-09 ,pp. : 441-442

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy: Interim Analysis from an Open-Label, Two-Stage Adaptive, Randomized, Controlled Trial

By Baron Ralf  

Clinical Drug Investigation, Vol. 29, Iss. 4, 2009-01 ,pp. : 231-241

Adis International

Access to resources Recommend Favorite